We are a Luxembourg non-profit association, recognized as a public utility, founded on June 25, 2015. The INC is mandated by the Ministry of Health and whose ambition is to federate and animate the players in cancerology, but also to frame and structure all areas of prevention, screening, diagnosis, treatment, rehabilitation and end-of-life care.
We act as a committed and determined pivotal player in the fight against cancer and in support care.
We work with integrity and neutrality to bring together healthcare professionals, label healthcare providers and disseminate our recommendations in the service of patients to harmonize best practices.
As a vector of humanist values, we encourage research with the overall aim of opening up, collaborating and sharing knowledge at national and international levels.
The Institut National du Cancer produces expert reports in the form of national recommendations, guidelines, reports and notices, in particular in response to referrals from parliamentary commissions and the relevant ministries.
Dedicated to beating cancer, we are working together to pave the way for tomorrow's structured, standardized treatments, both in terms of practices and patient pathways.
And also:
Our approach is based on evidence from scientific research, solidly grounded in an approach resulting from systematic data collection through observation, questioning and hypothesis testing.
Our decision-making is informed by this effective practice, which serves to improve the quality of patient care at every stage.
All our actions are part of an important process of improving productivity and sharing knowledge.
We manage skills at national and international level, in partnership with the main players in the fight against cancer, to ensure a convergence of knowledge aimed at structured, standardized care.
Our ambition is to make access to care fair for all patients, and to ensure their quality of life throughout their journey.
We want to ensure that everyone has what they need, according to their circumstances.
We are driven by scientific progress, supporting and promoting research, and the implementation of personalized treatments for patients, at the heart of our concerns.
We believe in innovation and scientific discovery to meet the needs and desires of tomorrow's patients. We believe that by opening ourselves up to the world, we make it easier to understand.
En 2023, la direction et les chargés de projets de l’INC ont poursuivi leur participation active aux travaux des différents groupes de travail (GT) du PNC2.
Dans ce cadre, l’INC a assumé le rôle actif dans tous les GT, notamment dans les activités suivantes :
This axis aims to improve the organization of oncology in Luxembourg by setting up a system for monitoring the incidence and evolution of cancers in the country, developing and networking existing skills, and improving the quality of care and healthcare management.
The structuring of data and the implementation of a system for collecting and exchanging this data is the key theme of this axis, which aims to contribute to the modernization of the country.
In line with the objectives of the first PNC, this axis will enable current patients' rights to be improved through their active involvement in decision-making bodies. The aim is to achieve greater transparency of information, as well as a dedicated training program.
The INC is a key player in this axis, notably through two major projects aimed at improving the Announcement of a cancer diagnosis in Luxembourg and setting up a national information platform for patients and their families.
The development of preventive measures for cancer, in synergy with other national plans, the evaluation and enrichment of screening programs, and the monitoring of cancer epidemiology and risk factors in the country, are envisaged in this axis.
Optimization of the diagnostic phase is an essential step towards patient stratification, enabling the implementation of personalized treatment and follow-up. Innovation in available methodologies, in line with scientific and medical progress, is an aspect to be addressed in the context of this axis.
Access to high-quality, safe, effective and patient-centered care and treatment, and the development of supportive care and patient support, including all aspects of oncofertility, are included in this axis.
This axis focuses on improving the quality and follow-up of patients from birth and in their geriatric years.
The last axis aims to develop clinical and translational research in the country, to increase participation in research, but also to establish international collaborations that are essential for patients.
Director
Legal Office and Finance Manager
Head of IT
Administrative assistant
Digital Communication Officer
European Collaborations Manager
TB projects manager
Guidelines & Patient pathways projects manager
Project manager
European Project Manager
European projects administrative assistant
Medical coordinator
The Executive Board oversees the implementation of actions under the delegated responsibility of the INC Board of Directors.
Chairman, MD
Vice President, MD
Secretary, MD
Treasurer
The Advisory board members represent the following INC founding members:
Chairman (the designated member of the National Cancer Platform)
Hôpitaux Robert Schuman
Société Luxembourgeoise d’Oncologie
Centre Hospitalier du Nord
Centre Hospitalier de Luxembourg
Centre Hospitalier Emile Mayrisch
Patiente Vertriedung
Fondation Cancer
Médiateur de la Santé
Centre François Baclesse
Fondation Kriibskrank Kanner
The Ministry of Health representative, Mr Tom RAUSCH (Prevention Policy Coordinator and Deputy General) also attends INC Board meetings as an observer.
Institutional sector :
DiSa: Direction de la Santé
M3S: Ministère la Santé et de la Sécurité sociale
CNS: Caisse Nationale de la Santé
INC: Institut National du Cancer
Luxinnovation
Associative sector :
Fondation Cancer Luxembourg
Fondatioun KriibskrankKanner
Patiente vertriedung
Europa dona
Think pink
Health and care sector :
CHL: Centre Hospitalier de Luxembourg
HRS: Hôpitaux Robert Schuman
CHEM: Centre Hospitalier Emile Mayrisch
CHdN: Centre Hospitalier du Nord
CFB: Centre François Baclesse
LNS: Laboratoire national de la santé
Omega 90
Centre de réhabilitation colpach
Research and education sector :
LIH: Luxembourg Institute of Health
CIEC: Clinical and Epidemiological Investigation
FNR: Fond national de la recherche
LISER: Luxembourg Institute of Socio-Economic Research
RNC: Registre National du Cancer
Université du Luxembourg
The Institut National du Cancer du Luxembourg (INC) invites you to discover its national and international projects dedicated to the fight against cancer. We are actively involved in the management and coordination of various initiatives and activities aimed at improving cancer care. Through a collaborative approach, we bring together key players in the healthcare sector, public authorities and international partners to implement concrete, effective actions.
Discover the commitment of the Institut National du Cancer du Luxembourg through our projects and activities!
The INC projects
Scroll
